This is a grant opportunity (PAR-25-040) from the NIH (HHS-NIH11) for research on schizophrenia and related disorders during mid- to late-life. It is an R21 Clinical Trial Optional grant (CFDA: 93.242).
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.